Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows – operating activities:
Net (loss)/earnings	$ (31)	$ (355)
Non-cash items –
Share-based plans expense	135	119
Treasury shares issued for 401(k) contribution	418	606
Depreciation and amortization	466	442
Investment/asset impairment charges, net	7	21
Loss on dispositions, net	3
Other charges and credits, net	99	10
Changes in assets and liabilities –
Accounts receivable	(570)	(328)
Unbilled receivables	(671)	(1,357)
Advances and progress billings	781	2,718
Inventories	(1,521)	(3,778)
Other current assets	(29)	(249)
Accounts payable	(95)	(264)
Accrued liabilities	(386)	(666)
Income taxes receivable, payable and deferred	26	(59)
Other long-term liabilities	(151)	(83)
Pension and other postretirement plans	(150)	(261)
Financing receivables and operating lease equipment, net	12	79
Other	41	43
Net cash used by operating activities	(1,616)	(3,362)
Cash flows – investing activities:
Payments to acquire property, plant and equipment	(674)	(567)
Proceeds from disposals of property, plant and equipment	3	11
Contributions to investments	(8,797)	(243)
Proceeds from investments	7,750	2,907
Other	1	(34)
Net cash (used)/provided by investing activities	(1,717)	2,074
Cash flows – financing activities:
New borrowings	29	27
Debt repayments	(295)	(4,442)
Employee taxes on certain share-based payment arrangements	(14)	(65)
Dividends paid on mandatory convertible preferred stock	(72)
Other	14	18
Net cash used by financing activities	(338)	(4,462)
Effect of exchange rate changes on cash and cash equivalents	12	(28)
Net decrease in cash & cash equivalents, including restricted	(3,659)	(5,778)
Cash & cash equivalents, including restricted, at beginning of year	13,822	12,713
Cash & cash equivalents, including restricted, at end of period	10,163	6,935
Less restricted cash & cash equivalents, included in Investments	21	21
Cash and cash equivalents at end of period	$ 10,142	$ 6,914